Molecular implications of skin lesions in tuberous sclerosis

American Journal of Dermatopathology

Volumn 30, Issue 3, 2008, Pages 256-261

  Jóźwiak, Jaroslaw ^a   Galus, Ryszard ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Akt; Erk; mTOR; Skin lesions; Tuberous sclerosis

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOPHENOL MONOOXYGENASE; PROTEIN KINASE B; PROTEIN KINASE;

ARTICLE; BENIGN TUMOR; CAFE AU LAIT SPOT; DISEASE COURSE; DOWN REGULATION; FOREHEAD; HEMANGIOFIBROMA; HUMAN; HYPOMELANOSIS; INCIDENCE; MELANOGENESIS; MOLECULAR DYNAMICS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAGREEN PATCH; SKIN DEFECT; SKIN DISCOLORATION; TUBEROUS SCLEROSIS; UPREGULATION; BIOSYNTHESIS; DNA MICROARRAY; GENETICS; METABOLISM; PATHOLOGY; REVIEW; SKIN DISEASE;

HUMANS; MELANINS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SKIN DISEASES; TUBEROUS SCLEROSIS; UP-REGULATION;

EID: 45849088058     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31816e22a5     Document Type: Article

References (47)

1. Roach E, Sparagana S. Diagnosis of tuberous sclerosis complex. J Child Neurol. 2004;19:643-649.
2. Webb DW, Clarke A, Fryer A, et al. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135:1-5.
3. Józwiak S. Diagnostic value of clinical features and supplementary investigations in tuberous sclerosis in children. Acta Paediatr Hung. 1992; 32:71-88.
4. Jóźwiak S, Schwartz RA, Janniger CK, et al. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998;37:911-917.
5. Fitzpatrick TB, Szabó G, Hori Y, et al. White leaf-shaped macules. Earliest visible sign of tuberous sclerosis. Arch Dermatol. 1968;98:1-6.
6. Chudnow RS, Wolfe GI, Sparagana SP, et al. Abnormal sudomotor function in the hypomelanotic macules of tuberous sclerosis complex. J Child Neurol. 2000;15:529-532.
7. Sperandio M, Weber L, Jauch A, et al. Cutaneous white spots in a child with polycystic kidneys: a clue to TSC2/PKD1 gene mutation. Nephrol Dial Transplant. 2000;15:909-912.
8. Alper JC, Holmes LB. The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol. 1983;1:58-68.
9. Vanderhooft SL, Francis JS, Pagon RA, et al. Prevalence of hypopigmented macules in a healthy population. J Pediatr. 1996;129:355-361.
10. Jansen AC, Sancak O, D'Agostino MD, et al. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol. 2006;60:528-539.
11. Anliker MD, Dummer R, Burg G. Unilateral agminated angiofibromas: a segmental expression of tuberous sclerosis? Dermatology. 1997;195: 176-178.
12. Roach ES, Smith M, Huttenlocher P, et al. Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol. 1992;7:221-224.
13. Hori K, Soejima K, Nozaki M, et al. Treatment of facial angiofibroma of tuberous sclerosis using cultured epithelial autografts. Ann Plast Surg. 2006;57:415-417.
14. La Placa M, Gibellini D, Bianchi T, et al. Overexpression of MLH-1 and psoriasin genes in cutaneous angiofibromas from tuberous sclerosis complex patients. J Cutan Pathol. 2006;33:608-613.
15. Penneys NS, Smith KJ, Nemeth AJ. Factor XIIIa in the hamartomas of tuberous sclerosis. J Dermatol Sci. 1991;2:50-54.
16. Maldonado MM, Baybis D, Newman DL, et al. Expression of ICAM-1, TNF-alpha, NFkappaB, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis. 2003;14:279-290.
17. Li S, Takeuchi F, Wang JA, et al. MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J Exp Med. 2005;202:617-624.
18. Sun XF, Yan CL, Fang L, et al. Cutaneous lesions and visceral involvement of tuberous sclerosis. Chin Med J (Engl). 2005;118:215-219.
19. Bell SD, MacDonald DM. The prevalence of café-au-lait patches in tuberous sclerosis. Clin Exp Dermatol. 1985;10:562-565.
20. Fahsold R, Rott HD, Lorenz P. A third gene locus for tuberous sclerosis is closely linked to the phenylalanine hydroxylase gene locus. Hum Genet. 1991;88:85-90.
21. Gutman I, Dunn D, Behrens M, et al. Hypopigmented iris spot. An early sign of tuberous sclerosis. Ophthalmology. 1982;89:1155-1159.
22. Kobayashi T, Urabe K, Winder A, et al. Tyrosinase-related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J. 1994;13:5818-5825.
23. Prota G. Some new aspects of eumelanin chemistry. Prog Clin Biol Res. 1988;256:101-124.
24. Yokoyama K, Suzuki H, Yasumoto K, et al. Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta. 1994; 1217:317-321.
25. Englaro W, Rezzonico R, Durand-Cle'ment M, et al. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem. 1995;270:24315-24320.
26. Burgering BM, Pronk GJ, van Weeren PC, et al. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 1993;12: 4211-4220.
27. Jozwiak J, Sahin M, Jozwiak S, et al. Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling. Int J Cardiol. Nov 23, 2007 [epub ahead of print].
28. Jozwiak J, Grajkowska W, Kotulska K, et al. Brain tumor formation in tuberous sclerosis depends on Erk activation. Neuromolecular Med. 2007; 9:117-127.
29. Dan HC, Sun M, Yang L, et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem. 2002;277:35364-35370.
30. Ma L, Chen Z, Erdjument-Bromage H, et al. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 2005;121:179-193.
31. Englaro W, Bertolotto C, Buscà R, et al. Inhibition of the mitogenactivated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem. 1998;273:9966-9970.
32. Steingrímsson E, Moore KJ, Lamoreux ML, et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet. 1994;8:256-263.
33. Bentley NJ, Eisen T, Goding CR. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol. 1994;14:7996-8006.
34. Bertolotto C, Busca R, Abbe P, et al. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol. 1998;18:694-702.
35. Yasumoto K, Yokoyama K, Takahashi K, et al. Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J Biol Chem. 1997; 272:503-509.
36. Hemesath TJ, Price ER, Takemoto C, et al. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature. 1998;391:298-301.
37. Xu W, Gong L, Haddad MM, et al. Regulation of microphthalmiaassociated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res. 2000;255:135-143.
38. Goding CR. Melanocyte development and malignant melanoma. Forum (Genova). 2000;10:176-187.
39. Dan HC, Sun M, Yang L, et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem. 2002;277:35364-35370.
40. Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol. 2002;4:658-665.
41. Dong J, Pan D. Tsc2 is not a critical target of Akt during normal Drosophila development. Genes Dev. 2004;18:2479-2484.
42. Han S, Santos TM, Puga A, et al. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Cancer Res. 2004;64:812-816.
43. Kim DS, Kim SY, Chung JH. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal. 2002;14: 779-785.
44. Zhang W, Tsan R, Nam DH, et al. Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT. Neoplasia. 2006;8:543-550.
45. Rosenwald IB, Kaspar R, Rousseau D, et al. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J Biol Chem. 1995;270:21176-21180.
46. Shantz LM, Pegg AE. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res. 1994;54:2313-2316.
47. Ohguchi K, Banno Y, Nakagawa Y, et al. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells. J Cell Physiol. 2005;205: 444-451.